基于网络药理学和分子对接探究柴胡-黄芩药对治疗老年胃食管反流病的作用机制*

王小兵 ,  陈熠灼 ,  王婧 ,  胡素芹 ,  胡洋 ,  罗磊 ,  李明彦 ,  张勤生

国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (6) : 37 -42.

PDF (6076KB)
国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (6) : 37 -42. DOI: 10.3969/j.issn.1674-7593.2026.06.006
论著

基于网络药理学和分子对接探究柴胡-黄芩药对治疗老年胃食管反流病的作用机制*

作者信息 +

Exploring the mechanism of action of the Bupleurum-Scutellaria herb pair in treating gastroesophageal reflux disease based on network pharmacology and molecular docking

Author information +
文章历史 +
PDF (6221K)

摘要

目的 结合网络药理学分析与分子对接模拟技术, 解析柴胡-黄芩药对干预老年胃食管反流病 (GERD) 的作用机制。方法 通过 TCMSP 数据平台检索柴胡、 黄芩的有效成分及作用靶点, 借助 GeneCards、OMIM 数据库收集 GERD 相关靶点, 制作韦恩图取交集, 并利用 Cytoscape 3. 10. 1 软件构建 “中药-成分-靶点” 网络图; 借助 STRING 数据库建立共同靶点的蛋白互作 (PPI) 网络; 基于 DAVID 数据库联合微生信平台, 完成共同靶点的基因本体 (GO) 功能注释与京都基因与基因组百科全书 (KEGG) 通路富集研究; 使用 AutoDockTools 分子模拟软件将关键活性化合物与核心作用靶点进行对接验证。结果 得到柴胡-黄芩治疗老年 GERD 的潜在靶点 111 个。 预测槲皮素、 山柰酚、 汉黄芩素、β-谷甾醇、 黄芩素等为柴胡-黄芩治疗老年 GERD 的关键活性成分, 丝氨酸/ 苏氨酸蛋白激酶、 肿瘤坏死因子、 白细胞介素-6、 白细胞介素-1β 等为治疗核心靶点。KEGG 结果显示, 柴胡-黄芩治疗老年 GERD 的作用途径包括化学致癌-活性氧信号途径、PI3K-Akt 信号途径、MAPK 信号途径、IL-17 信号途径等。 分子对接展示, 柴胡-黄芩关键成分与核心靶点间展现出显著的配体-受体结合效能及构象稳定性。结论 柴胡-黄芩药对通过影响细胞表达、 炎症反应、 氧化应激等过程从多靶点、 多通路起到治疗老年 GERD 的作用, 为临床应用中应用柴胡-黄芩疏肝清热法治疗老年 GERD 提供参考依据。

Abstract

Objective To explore the mechanism of the Bupleurum-Scutellaria herb pair in treating gastroesophageal reflux disease (GERD) in the elderly by comprehensively applying network pharmacology methods and molecular docking techniques. Methods The effective components and target information of Bupleurum -Scutellaria were retrieved through the TCMSP data platform, collected relevant targets of GERD in the elderly using Gene Cards and OMIM databases, created a Venn diagram to obtain the common targets, and the “TCM-component-target” network diagram was constructed using Cytoscape 3. 10. 1 software; the STRING database were used to construct a protein-protein interaction (PPI) network of common targets. Gene Ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed using the DAVID database and the Bioinformatics platform. AutoDockTools molecular simulation software were used to perform docking validation of key active compounds with core target sites. Results 111 intersection targets between Bupleurum-Scutellaria and GERD in the elderly were obtained. It is predicted that quercetin, kaempferol, wogonin, β-sitosterol, baicalein, etc. were the key active ingredients in the treatment of GERD in the elderly with Bupleurum and Scutellaria, and that serine/ threonine protein kinase, tumor necrosis factor, interleukin-6, interleukin-1β, etc. were the core targets for treatment. KEGG results showed that the pathways of action of Bupleurum-Scutellaria in the treatment of GERD in the elderly included chemical carcinogenesis-reactive oxygen species signaling pathway, PI3K-Akt signaling pathway, MAPK signaling pathway, and IL-17 signaling pathway. Molecular docking studies showed that the key components of Bupleurum-Scutellaria exhibited significant ligand-receptor binding efficiency and conformational stability with core targets. Conclusion The drug pair of Bupleurum-Scutellaria plays a role in the treatment of GERD in the elderly from multi-targets and multi-pathways by affecting cell expression, inflammatory response, oxidative stress and other processes, which provides a reference basis for the application of Bupleurum-Scutellaria liver-sparing and heat-cleansing method for the treatment of GERD in the elderly in clinical therapy.

关键词

柴胡-黄芩药对 / 老年胃食管反流病 / 网络药理学 / 分子对接 / 作用机制

Key words

Bupleurum-Scutellaria herb pair / Gastroesophageal reflux disease in the elderly / Network pharmacology / Molecular docking / Mechanism of action

引用本文

引用格式 ▾
王小兵,陈熠灼,王婧,胡素芹,胡洋,罗磊,李明彦,张勤生. 基于网络药理学和分子对接探究柴胡-黄芩药对治疗老年胃食管反流病的作用机制*[J]. 国际老年医学杂志, 2026, 47(6): 37-42 DOI:10.3969/j.issn.1674-7593.2026.06.006

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Jung H K, Tae C H, Song K H, et al. 2020 Seoul consensus on the diagnosis and management of gastroesophageal reflux disease [ J ]. J Neurogastroenterol Motil, 2021, 27(4): 453-481.

[2]

Eusebi L H, Ratnakumaran R, Yuan Y, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis[J]. Gut, 2018, 67(3): 430-440.

[3]

胡洋, 胡素芹, 罗磊, 等. 老年肝胃郁热型反流性食管炎中医药治疗的研究进展[J]. 中国老年学杂志, 2025, 45(1): 238-241.

[4]

Hu Y, Hu S Q, Luo L, et al. Research progress on traditional Chinese medicine treatment of reflux esophagitis of liver and stomach stagnation heat type in the elderly [J]. Chin J Gerontol, 2025, 45(1): 238-241.

[5]

毛一清, 赵迎盼, 胡蓝烁, 等. 《胃食管反流病中医诊疗专家共识(2023)》解读[J]. 中国中西医结合消化杂志, 2024, 32(9): 764-770.

[6]

Mao Y Q, Zhao Y P, Hu L S, et al. Interpretation of the expert consensus on traditional Chinese medicine diagnosis and treatment of gastroesophageal reflux disease (2023)[J]. Chin J Integr Tradit West Med Dig, 2024, 32(9): 764-770.

[7]

李洁莲, 刘婉敏, 董明国, 等. 现代中医文献中中药治疗岭南地区胃食管反流病用药规律的数据挖掘 [J]. 广州中医药大学学报, 2023, 40 (10 ): 2666-2671.

[8]

Li J L, Liu W M, Dong M G, et al. Data mining of medication rules of Chinese medicine for gastroesophageal reflux disease in Lingnan area recorded in modern Chinese medical literature [J]. J Guangzhou Univ Tradit Chin Med, 2023, 40(10): 2666-2671.

[9]

任海伟, 彭丹妮, 魏浛夷, 等. 基于网络药理学和分子对接分析柴胡抗氧化应激作用机制[J]. 食品研究与开发, 2025, 46(8): 80-89.

[10]

Ren H W, Peng D N, Wei H Y, et al. Network pharmacology and molecular docking reveal anti-oxidative stress mechanism of bupleuri radix[J]. Food Res Dev, 2025, 46(8): 80-89.

[11]

Liu Y, Yang X, Gan J, et al. CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting [J]. Nucleic Acids Res, 2022, 50(W1): W159-W164.

[12]

Sun Z, Wang Y, Pang X, et al. Mechanisms of polydatin against spinal cord ischemia-reperfusion injury based on network pharmacology, molecular docking and molecular dynamics simulation[J]. Bioorg Chem, 2023, 140: 106840.

[13]

中华中医药学会脾胃病分会. 胃食管反流病中医诊疗专家共识(2023) [J]. 中医杂志, 2023, 64 (18): 1935-1944.

[14]

Chinese Association of Chinese Medicine Spleen-Stomach Disease Branch. Expert consensus on the diagnosis and treatment of gastroesophageal reflux disease with Traditional Chinese Medicine (2023) [J]. J Tradit chin Med, 2023, 64(18): 1935-1944.

[15]

李金儒, 龙丹, 朱莹. 从“土得木而达”辨治胃食管反流病[J]. 南京中医药大学学报, 2024, 40 (2): 88-92.

[16]

Li J R, Long D, Zhu Y. Exploration on differentiation and treatment of gastroesophageal reflux disease under the theory of earth being dredged by wood [J]. J Nanjing Univ Tradit Chin Med, 2024, 40(2): 88-92.

[17]

许雨晴, 赵唯含. 柴胡类方治疗胃食管反流病研究进展[J]. 西部中医药, 2024, 37(12): 102-104.

[18]

Xu Y Q, Zhao W H. Research progress in Chaihu prescriptions in the treatment of gastroesophageal reflux disease[J]. West J Tradit Chin Med, 2024, 37(12): 102-104.

[19]

阮清锋, 章丹, 王富乾, 等. 黄芩临床应用、化学成分、药理作用及其质量标志物(Q-Marker) 预测分析 [J]. 时珍国医国药, 2025, 36(8): 1534-1541.

[20]

Ruan Q F, Zhang D, Wang F Q, et al. Predictive analysis on clinical applications, chemical constituents, pharmacological effects, and quality markers of Scutellariae Radix[J]. J Li Shizhen Tradit Chin Med, 2025, 36 (8): 1534-1541.

[21]

李慧. 基于 NF-κB 信号通路调控的黄酮类化合物抗炎活性及抗炎/ 抗氧化联运机制[D] . 武汉: 华中农业大学, 2019.

[22]

Li H. Anti-inflammation and anti-inflammatory/ antioxidant linkage mechanismof flavonoids based on NF-κB sig-naling pathway[D] . Wuhan: Huazhong Agricultural U-niversity, 2019.

[23]

张娟, 张明, 何静波. 槲皮素对反流性食管炎大鼠炎症因子调控作用研究[J]. 包头医学院学报, 2025, 41(3): 54-58.

[24]

Zhang J, Zhang M, He J B. Study on the regulatory effect of quercetin on inflammatory factors in rats with re-flux esophagitis[J]. J Baotou Med Coll, 2025, 41(3): 54-58.

[25]

秦华珍, 戴庆玲, 陈俊其, 等. 黄酮类成分抗胃溃疡的药效及作用机制研究进展[J]. 湖北农业科学, 2022, 61(11): 145-148, 157.

[26]

Qin H Z, Dai Q L, Chen J Q, et al. Research progress on the efficacy and mechanism of flavonoids on gastric ulcer [J]. Hubei Agric Sci, 2022, 61(11): 145-148, 157.

[27]

张文文, 向施, 陈慧, 等. β-谷甾醇对肿瘤的防治作用及其机制研究进展[J]. 医药导报, 2024, 43(5): 757-761.

[28]

Zhang W W, Xiang S, Chen H, et al. Research progress on the protective effects and mechanism of β-sitosterol in the prevention and treatment of cancer [J]. Her Med, 2024, 43(5): 757-761.

[29]

Revathidevi S, Munirajan A K . Akt in cancer: mediator and more[J]. Semin Cancer Biol, 2019, 59: 80-91.

[30]

Zhang Q, Wen F, Sun F, et al. Efficacy and mechanism of quercetin in the treatment of experimental colitis using network pharmacology analysis [J]. Molecules, 2022, 28(1): 36615338.

[31]

Si X, Lin W, Chen Z, et al. Atractylenolide Ⅲ ameliorated reflux esophagitis via PI3K/ AKT/ NF-κB/ iNOS pathway in rats[J]. Heliyon, 2023, 9(11): e21224.

[32]

张锋利, 唐凤英, 沈舒文, 等. 桔梗枳壳汤加味对反流性食管炎模型大鼠 PI3K/ Akt 信号通路及胃肠动力的影响[J]. 中医药导报, 2020, 26(10): 36-41.

[33]

Zhang F L, Tang F Y, Shen S W, et al. Effect of modified Jiegeng Zhike decoction on PI3K/ Akt signal pathway and gastrointestinal motility in rats with reflux esophagitis [J]. Guid J Tradit Chin Med Pharmacol, 2020, 26 (10): 36-41.

[34]

Zavala-Solares M R, Fonseca-Camarillo G, Valdovinos M, et al. Gene expression profiling of inflammatory cytokines in esophageal biopsies of different phenotypes of gastroesophageal reflux disease: a cross-sectional study [J]. BMC Gastroenterol, 2021, 21(1): 201.

[35]

Peng D, Lu H, Zhu S, et al. NRF2 antioxidant response protects against acidic bile salts-induced oxidative stress and DNA damage in esophageal cells[J]. Cancer Lett, 2019, 458: 46-55.

[36]

Varfolomeev E, Vucic D . Intracellular regulation of TNF activity in health and disease[J]. Cytokine, 2018, 101: 26-32.

[37]

Braicu C, Buse M, Busuioc C, et al. A comprehensive review on MAPK: a promising therapeutic target in cancer [J]. Cancers, 2019, 11(10): 1618.

[38]

Shin M R, An H J, Seo B I, et al. Anti-apoptotic effect of banhasasim-Tang on chronic acid reflux esophagitis [J]. World J Gastroenterol, 2017, 23(25): 4644-4653.

[39]

Chwiesko A, Baniukiewicz A, Semeniuk J, et al. Activi-ty of mitogen-activated protein kinases in the esophageal epithelium of patients with Barrett􀆳s esophagus: MAPK activity in Barrett􀆳s esophagus[J]. Dis Esophagus, 2015, 28(6): 585-592.

[40]

张岱泽, 王坤宁, 彭程, 等. 基于调控 p38 丝裂原活化蛋白激酶信号通路治疗胃食管反流病作用机制的中西医研究进展[J]. 中国中西医结合外科杂志, 2024, 30(6): 929-932.

[41]

Zhang D Z, Wang K N, Peng C, et al. Research pro-gress of Chinese and western medicine on the mechanism of treating gastroesophageal reflux disease based on regu-lating p38 mitogen-activated protein kinase signal path-way[J]. Chin J Surg Integr Tradit West Med, 2024, 30 (6): 929-932.

[42]

Rieder F, Biancani P, Harnett K, et al. Inflammatory mediators in gastroesophageal reflux disease: impact on e-sophageal motility, fibrosis, and carcinogenesis[J]. Am J Physiol Gastrointest Liver Physiol, 2010, 298 (5): G571-G581.

[43]

陈昶洲, 李莉, 张雯, 等. 马齿苋多糖对反流性食管炎大鼠的作用及相关机制实验研究[J]. 陕西医学杂 志, 2023, 52(6): 651-654.

[44]

Chen C Z, Li L, Zhang W, et al. Experimental study on the effect of purslane polysaccharide on reflux esophagitis in rats and its related mechanism[J]. Shaanxi Med J, 2023, 52(6): 651-654.

[45]

徐中, 赵健雄, 王学习, 等. 疏肝和胃降逆汤对反流性食管炎大鼠食管组织 IL-23/ IL-17 轴的影响[J]. 时珍国医国药, 2010, 21(12): 3200-3202.

[46]

Xu Z, Zhao J X, Wang X X, et al. Effect of Shugan he-wei jiangni decoction on IL-23/ IL-17 axis of esophageal tissue in rats with reflux esophagitis[J]. Lishizhen Med Mater Med Res, 2010, 21(12): 3200-3202.

[47]

吴小芳, 尹方, 吴英芬, 等. 幽门螺杆菌感染胃癌发生风险与 TP53 基因多态性分析[J]. 中华医院感染学杂志, 2021, 31(9): 1301-1304.

[48]

Wu X F, Yin F, Wu Y F, et al. Risk of gastric cancer in patients with Helicobacter py lori infection and TP53 gene polymorphism [J]. Chin J Nosocomiology, 2021, 31(9): 1301-1304.

[49]

Stoehr R, Weisser R, Wendler O, et al. P53 codon 72 polymorphism and risk for squamous cell carcinoma of the penis: a Caucasian case-control study [J]. J Cancer, 2018, 9(22): 4234-4241.

基金资助

*国家自然科学基金资助项目(82305074)

国家中医药管理局中国中医药科技发展中心联合研究项目(CXZH202304)

河南省中医药传承与创新人才工程 (仲景工程) 中医药学科领军人才项目(豫卫中医函 [2021] 08 号)

AI Summary AI Mindmap
PDF (6076KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉